Saeid Ghavami

InstitutionUniversity of Manitoba
AddressWinnipeg
Manitoba
Canada
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 16 Covid-19 publications, with a maximum of 3 publications in January 2021
    All Publications
    Bar chart showing 133 publications over 18 distinct years, with a maximum of 17 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Seyfoori A, Shokrollahi Barough M, Mokarram P, Ahmadi M, Mehrbod P, Sheidary A, Madrakian T, Kiumarsi M, Walsh T, McAlinden KD, Ghosh CC, Sharma P, Zeki AA, Ghavami S, Akbari M. Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID). Int J Mol Sci. 2021 Jun 28; 22(13). PMID: 34203268.
      Citations: 2     Fields:    Translation:Humans
    2. Siri M, Dastghaib S, Zamani M, Rahmani-Kukia N, Geraylow KR, Fakher S, Keshvarzi F, Mehrbod P, Ahmadi M, Mokarram P, Coombs KM, Ghavami S. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses. Int J Mol Sci. 2021 Jun 01; 22(11). PMID: 34206057.
      Citations: 4     Fields:    Translation:HumansCells
    3. Habibzadeh P, Mofatteh M, Silawi M, Ghavami S, Faghihi MA. Molecular diagnostic assays for COVID-19: an overview. Crit Rev Clin Lab Sci. 2021 09; 58(6):385-398. PMID: 33595397.
      Citations: 6     Fields:    Translation:Humans
    4. Sharma P, McAlinden KD, Ghavami S, Deshpande DA. Chloroquine: Autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check? Eur J Pharmacol. 2021 Apr 15; 897:173928. PMID: 33545161.
      Citations: 3     Fields:    Translation:Humans
    5. Peymani P, Dehesh T, Aligolighasemabadi F, Sadeghdoust M, Kotfis K, Ahmadi M, Mehrbod P, Iranpour P, Dastghaib S, Nasimian A, Ravandi A, Kidane B, Ahmed N, Sharma P, Shojaei S, Bagheri Lankarani K, Madej A, Rezaei N, Madrakian T, Los MJ, Labouta HI, Mokarram P, Ghavami S. Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients. Transl Med Commun. 2021; 6(1):3. PMID: 33521322.
      Citations: 13     
    6. Nabavi SF, Habtemariam S, Berindan-Neagoe I, Cismaru CA, Schaafsma D, Ghavami S, Banach M, Aghaabdollahian S, Nabavi SM. Rationale for Effective Prophylaxis Against COVID-19 Through Simultaneous Blockade of Both Endosomal and Non-Endosomal SARS-CoV-2 Entry into Host Cell. Clin Transl Sci. 2021 03; 14(2):431-433. PMID: 33406317.
      Citations: 4     Fields:    Translation:HumansCells
    7. Darbeheshti F, Abolhassani H, Bashashati M, Ghavami S, Shahkarami S, Zoghi S, Gupta S, Orange JS, Ochs HD, Rezaei N. Coronavirus: Pure Infectious Disease or Genetic Predisposition. Adv Exp Med Biol. 2021; 1318:91-107. PMID: 33973174.
      Citations: 1     Fields:    Translation:Humans
    8. Mehrbod P, Hudy D, Shyntum D, Markowski J, Los MJ, Ghavami S. Quercetin as a Natural Therapeutic Candidate for the Treatment of Influenza Virus. Biomolecules. 2020 12 24; 11(1). PMID: 33374214.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    9. Shojaei S, Suresh M, Klionsky DJ, Labouta HI, Ghavami S. Autophagy and SARS-CoV-2 infection: Apossible smart targeting of the autophagy pathway. Virulence. 2020 12; 11(1):805-810. PMID: 32567972.
      Citations: 34     Fields:    Translation:HumansCellsPHPublic Health
    10. Habibzadeh P, Mofatteh M, Ghavami S, Roozbeh J. The potential effectiveness of acetazolamide in the prevention of acute kidney injury in COVID-19: A hypothesis. Eur J Pharmacol. 2020 Dec 05; 888:173487. PMID: 32805256.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    11. Habtemariam S, Berindan-Neagoe I, Cismaru CA, Schaafsma D, Nabavi SF, Ghavami S, Banach M, Nabavi SM. Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19: Shoot the messenger! J Cell Mol Med. 2020 09; 24(17):10267-10269. PMID: 32677763.
      Citations: 2     Fields:    Translation:HumansAnimals
    12. Drozdzal S, Rosik J, Lechowicz K, Machaj F, Kotfis K, Ghavami S, Los MJ. FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. Drug Resist Updat. 2020 12; 53:100719. PMID: 32717568.
      Citations: 34     Fields:    Translation:HumansAnimals
    13. Sureda A, Alizadeh J, Nabavi SF, Berindan-Neagoe I, Cismaru CA, Jeandet P, Los MJ, Clementi E, Nabavi SM, Ghavami S. Endoplasmic reticulum as a potential therapeutic target for covid-19 infection management? Eur J Pharmacol. 2020 Sep 05; 882:173288. PMID: 32561291.
      Citations: 25     Fields:    Translation:HumansCellsPHPublic Health
    14. Citations: 55     Fields:    Translation:HumansCellsPHPublic Health
    15. Habtemariam S, Nabavi SF, Ghavami S, Cismaru CA, Berindan-Neagoe I, Nabavi SM. Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2. Pharmacol Res. 2020 07; 157:104853. PMID: 32360584.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    Ghavami's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (280)
    Explore
    _
    Co-Authors (116)
    Explore
    _
    Similar People (60)
    Explore
    _